The Global Pta Balloon Catheter Market Size Is Expected To Exhibit A Cagr Of 6.8% Over The Forecast Period (2018 – 2026).
The term "percutaneous transluminal angioplasty" stands for "percutaneous transluminal angioplasty." The tip of the PTA balloon catheter is an inflatable 'balloon' that is used during a minimally invasive catheterization procedure. The purpose of this procedure is to widen the narrowed vessel opening. The deflated balloon is placed in the narrowed space, inflated for a short time, and then deflated before being removed. PTA balloons are available in a variety of sizes, lengths, and shapes, depending on the anatomy they're meant to treat. For the treatment of peripheral vascular lesions, PTA balloon catheters can be used in two ways. One method is to dilate the lumen of a clogged blood vessel. This procedure is known as 'plain-old balloon angioplasty' (POBA). The second application is for expanding stents to treat vascular blockages.
The global PTA balloon catheter market size was valued at US$ 1,127.7 million in 2017, and is expected to exhibit a CAGR of 6.8% over the forecast period (2018 – 2026).
The report on the Global PTA Balloon Catheter Market provides a comprehensive analysis of the market for the forecast period. The report includes several sections as well as an analysis of the market's major trends and factors. The market dynamics include the drivers, restraints, opportunities, and challenges that are used to outline the impact of these factors on the market. The market's intrinsic factors are the drivers and restraints, while the market's extrinsic factors are the opportunities and challenges. The Global PTA Balloon Catheter Market report forecasts the market's revenue growth over the forecast period.
The rising prevalence of cardiovascular disorders and peripheral artery disease, as well as the growing geriatric population and the rise in minimally invasive surgeries, are expected to propel the PTA balloon catheter market forward. Furthermore, rising hospitalisation combined with an increase in cardiovascular disorders is expected to increase PTA balloon catheter adoption. Furthermore, rising PTA balloon catheter production and the number of FDA approvals for the product are expected to propel the global market forward. For example, the US FDA approved Medtronic Inc.'s PACT Admiral Paclitaxel coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter in April 2018. The risks and complications associated with catheters, on the other hand, may slow the market's growth.
Comments
Post a Comment